| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  TidalSense The respiratory intelligence company TidalSense, formerly Cambridge Respiratory Innovations, is a venture-backed respiratory technology company headquartered in Cambridge UK. TidalSense builds AI-driven diagnostic and monitoring solutions for respiratory medicine built on the foundation of the company's novel patented sensor technology, N-Tidal, which provides unprecedented insight into lung physiology through high accuracy, rapid sampled CO2, unlike anything seen before in clinical medicine. | 0 | 0 | 0 | 21 |
 | Anocca Engineered Immunity Anocca understands the complexity of T-cell biology. We have established a unique technology platform that replicates functional human cellular immunobiology and unlocks the potential of T-cell immunotherapies and vaccine strategies that leverage T-cell immunity. Anocca’s approach and proprietary technologies deliver the means to efficiently and precisely harness and manipulate T-cell immunity, enabling a range of next-generation therapies and vaccination strategies that address unmet patient need in oncology, infectious disease and autoimmunity. Today Anocca has a focus on delivering T-cell receptor-modified T-cell therapies (TCR-T) in oncology. Anocca is rapidly progressing a pipeline of novel therapeutic TCR-T candidates generated entirely … Type: | 0 | 0 | 0 | 100 |
 | Dualyx Discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. We aim to create long-lasting treatments for patients with a high unmet medical need. | 0 | 0 | 0 | 15 |
 | Saphenus Medical Technology [Automatic translation follows] A new therapy for less pain and safe walking after amputation. With the sensory feedback system Suralis. Saphenus is a manufacturer of sensory feedback systems with the aim of improving the quality of life of people with leg and foot prostheses. "The prosthesis should adapt to the person and not the other way around" is one of Saphenus' core messages. Saphenus has developed a multi-stage therapy specifically for people who have lost a limb and are complaining of pain, which combats pain and at the same time improves the quality of walking. Saphenus works with leading research … Type: | 1 | 1 | 0 | 15 |
 | HĀTO AI-powered cardiac analysis HATO is a software as a medical device (SaMD) that will change how we deal with cardiovascular disease detection. Through advanced Deep Learning and intuitive software we tend to ease the burden in the healthcare system with early detection, enhanced risk stratification and increased prevension. ECG Analysis Software, Artificial Intelligence, HealthTech, and MedTech Type: | 1 | 0 | 1 | 5 |
 | Grassa | Unlocking the full potential of Grass | Biomass Green refined solutions Grassa extracts protein from leafy biomass. The proteins are suitable for consumption by people and animals. It is a great alternative to soy, even with better nutritional value. The protein has a neutral taste and color and has various functionalities. It is a novel vegetable protein that can be used as an ingredient in foods to replace animal proteins. The pricing of the proteins is the same as currently used animal and vegetable proteins, but the protein can be produced substantially more sustainably with no land use and little energy. Feedstock for the process is produced everywhere … Type: | 1 | 1 | 1 | 12 |
 |  Capitainer Convenient and quantitative blood sampling at the fingertip for everyone, everywhere at anytime. We have developed a microsystem based technology that offers a solution for near-patient blood sampling e.g. at home. Patients can themselves conveniently leave blood samples (as dried blod spots) and send it by mail to a laboratory for analysis. This is possible through our new disposable sampling chip that can meter and store an exact blood volume which allows for quantitative measurements, something that so far not has been possible. This is of particular importance for patients requiring continuous therapeutic drug monitoring. Our technology will reduce the … Type: | 2 | 0 | 2 | 26 |
 | Addex Therapeutics Allosteric modulators for Human Health Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention. Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is poised to start a pivotal registration clinical trial … Type: | 2 | 0 | 2 | 25 |
 | PeriVision Helping eye doctors save vision with AI, virtual reality and the cloud Vision is the most dominant of our senses. Yet, 2.2 billion people suffer from vision impairments of which 50% could be prevented or cured. And this number is growing due to our ageing populations and modern lifestyles. At the same time healthcare systems have limited resources. Eye care lags behind in the digital transformation and novel technology is not fully leveraged. As a result, people lose vision that do not have to. We combine AI algorithms, virtual reality and cloud computing to build the next generation systems to … Type: | 8 | 1 | 8 | 14 |
 | Hamlet BioPharma An innovative pharmaceutical company with a broad portfolio of projects for the treatment of cancer and infections Hamlet BioPharma AB is a pharmaceutical company with strong links to research, working with natural and biological substances. The company was formed through the merger of two pharmaceutical companies, Hamlet Pharma AB and SelectImmune Pharma AB, and is listed on the Spotlight Stock Market. Hamlet BioPharma is a formidable pharmaceutical company specializing in the development of drugs for the treatment of cancer and infectious diseases. The company has a portfolio of a total of ten drug projects, three of which are in Phase … Type: | 0 | 0 | 0 | 8 |
 | 2EyesVision Seeing is Believing 👁️🚀 Evolving the ophthalmology industry with disruptive products, 2EyesVision is a startup specializing in creating, developing, and commercializing innovative ophthalmic technologies. Our mission is to help eye care professionals to deliver high quality and personalized solutions to patients. With technologies like SimVis Gekko, we are committed to challenge the global premium ophthalmology market to redefine the future of visual health. | 0 | 0 | 0 | 20 |
 | Diamyd Medical Developing precision medicine therapies for Type 1 Diabetes Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for Type 1 Diabetes. The therapeutic diabetes vaccine Diamyd , an antigen-specific immunotherapy for the preservation of endogenous insulin production, is being evaluated in the ongoing Phase III trial DIAGNODE-3. The company is establishing a vaccine manufacturing facility in Umeå for the manufacture of recombinant GAD65, the active ingredient in the diabetes vaccine. Diamyd Medical also develops the GABA-based investigational drug Remygen® as a therapy for regeneration of endogenous insulin production and to improve hormonal response to hypoglycaemia. Diamyd Medical is … Type: | 3 | 0 | 2 | 40 |
 | Occlutech Every beat counts. Occlutech strives to provide the best possible treatment for serious heart conditions through the development and manufacture of minimally invasive cardiac devices. Since the start of Occlutech in 2003, our products have helped thousands of patients. We are determined to continuously grow our efforts and the number of lives improved. Every beat counts. Structural heart disease, Heart failure, Congenital Heart Disease, Stroke Prevention, Adult Intervention, ASD closure, PFO closure, Paravalvular Leak closure, PDA closure, and VSD closure | 0 | 0 | 0 | 256 |
 | Panaxium The BCI to Heal the Human Brain. Toronto, Canada and Aix-en-Provence, France. Together with world-renowned surgeons, neurologists, and neuroscientists, Panaxium is developing an iontronic precision neuro-stimulation BCI therapy to help restore normalcy for the 100 Million people worldwide who have survived a brain injury and are living with devastating cognitive, motor, and speech impairments. | 3 | 2 | 2 | 20 |
 | InflaRx N.V. An innovative biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system. InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI USA. Type: | 1 | 0 | 1 | 50 |
 | Hemerion Therapeutics A new player committed to tackle #glioblastoma and #brain #cancer Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma. Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma. Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer. Type: | 37 | 4 | 19 | 16 |
 | HEARTNET | Techstars '23 Solving fake and falsified medicines. Solving the $200billion epidemic of fake and falsified medicine Trade in counterfeited and falsified drugs has reached over 200 Billion dollars and the WHO warns that this problem is going to get worse. Hundreds of thousands of deaths are caused by faked and falsified drugs in Africa every year. We help Pharmaceuticals comply with track and trace to fight fake and falsified drugs. Type: | 1 | 0 | 1 | 3 |
 | Legit.Health Artificial Intelligence software for early detection, evaluation and monitoring of skin diseases. Legit.Health deploys computer vision and artificial intelligence technology to enable lifesaving diagnosis and therapies for skin diseases. Our goal is to enable universal access to high-quality diagnosis of pathologies and to offer affordable health assistance to everyone everywhere. With image recognition and AI-Driven recommendations, we bring leading technology to empower patients and care providers achieving better and faster clinical decisions. Contact: hello@legit.health Social media: instagram.com/legit.health facebook.com/LegitHealth twitter.com/LegitHealth_ Deep Learning, Machine Learnig, Skin Analyzation, Skin care, Artificial Intelligence, Health, Cancer Detector, Healthcare, Skin Cancer Detection, Digital health, and Patient … Type: | 9 | 1 | 9 | 27 |
 | EpiCapture Limited Discovery and development of liquid biopsy tests for early detection and prognostic assessment of cancer. EpiCapture's mission is to improve the care of cancer patients through the development of accurate, non-invasive, urine tests to identify aggressive cancers. EpiCapture-prostate is the company's first product to progress to commercialisation. In vitro diagnostics | 0 | 0 | 0 | 3 |
 | LiberaBio Addressing "undruggable" oncology targets by delivering whole antibodies inside the tumor and metastatic cells. LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins. Oncology, Nanomedicine, Drug delivery, Antibodies, Biosimilars, Active targeting, Intracellular, Oncoproteins, and Cytotoxics Type: | 2 | 0 | 2 | 11 |
 | Genomtec SA Molecular diagnosis everywhere, at the right time and for the right price. Genomtec is a MedTech company specializing in the development of advanced technologies in the field of genetic diagnostics. The company's flagship project is the Genomtec ID mobile diagnostic system, which allows for fast and precise molecular analysis outside the laboratory environment without the need to involve qualified laboratory personnel. The company has EU CE-IVD certification for the Genomtec ID RP5-PLEX diagnostic panel, which simultaneously detects the presence of the most common respiratory tract infections. The solution uses microfluidic technology and proprietary patented SNAAT® isothermal technology. The Genomtec technology … Type: | 0 | 0 | 0 | 25 |
 | PD Neurotechnology Ltd. Medical solutions PD Neurotechnology Ltd is a high-tech medical device company, founded in London, UK. The Greek Branch is based in Athens, Greece and the main activity of the company is carried out in the R&D and production, which is located in Ioannina, Greece. The company focuses its activities on researching, developing, producing and selling wearable medical devices and solutions for monitoring and supporting treatment of movement disorders. Its first solution is PDMonitor which is a sophisticated expert eco-system for patients with Parkinson’s Disease. Type: | 0 | 0 | 0 | 28 |
 | NUCAPS 🔬 New encapsulation technology for the industrial development of Nanocapsules and Biocapsules 💊 Green Nanotechnology NUCAPS@ is a consortium comprised by two Pharmaceutical companies (Laboratorios Cinfa and IDIFARMA), a Food Technological Center (CNTA) and the University of Navarra. T his consortium has developed new solutions based on the use of Food proteins (GRAS) as casein, zein or soya for the oral delivery and controlled release of drugs/actives and/or microorganisms. Nanotechnology, Encapsulation, Nanoencapsulation, Microencapsulation, Food, Nutrition, Cosmetic, Farmaceutic, and Pharmaceutical Type: | 3 | 1 | 3 | 21 |
 | SynaptixBio Ltd. Developing therapies for severe leukodystrophies Overview SynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases. SynaptixBio’s mission is to deliver gene therapies for fatal leukodystrophies in children caused by loss of function or mutation in a single gene. Using a breadth of platforms including antisense oligonucleotide (ASO)-based technology, we can silence the expression of the toxic gene to reverse disease progression. This approach will create life saving treatments for severe genetic diseases that affect the central nervous system. Pharmaceutical, Biotech, Leukodystrophy, Rare Disease, H-ABC, Hypomyelination, Basal Ganglia, Cerebrllum, Neurology, … Type: | 2 | 0 | 2 | 3 |
 | Madglove Amsterdam Helping people get a grasp on hand spasticity. We are a dynamic medical aid start-up founded by a team of five young and ambitious individuals. Our co-founders bring a diverse range of expertise, including physiotherapy, rehabilitation sciences, sport sciences, biological sciences, and business. This unique combination of backgrounds allows us to approach our mission from multiple angles, leveraging our collective knowledge to drive innovation. In addition to our talented team, we have established a robust network comprising rehabilitation clinics, esteemed scientists, and seasoned entrepreneurs. This network serves as a valuable resource, providing us with invaluable insights and information to shape … Type: | 5 | 1 | 5 | 5 |
 | Synaptiq.io Transforming cancer treatment through AI-assisted radiotherapy Welcome to Synaptiq, where we are revolutionizing cancer treatment through AI-driven radiotherapy solutions. Our focus is on developing advanced software that increases the efficiency of radiotherapy by automating the contouring process. One of the most time-consuming and tedious parts of radiotherapy treatment is contouring tumors and organs at risk. With traditional methods, this task can take up to 4 hours. However, our AI-powered solution can reduce it to as little as 5 minutes. Join us in our mission to improve patient outcomes and revolutionize cancer care through the power of AI technology. #radiotherapy #AIinmedicine … Type: | 1 | 1 | 0 | 21 |
 | Tekcapital plc We launch startups with university research to improve quality of life, and provide a suite of innovative IP services. Tekcapital is a global IP investment and tech transfer company founded in Oxford, England. We have built the world's largest university research network, sourcing IP from 4,500 institutions in 160 countries to help our clients create lasting value from new discoveries. We believe universities, taken together, create the world’s largest idea factory. Our goal is to provide effective, rapid and low-cost solutions for companies to source the IP they need for a sustainable competitive advantage. Our offerings help you find and … | 0 | 0 | 0 | 19 |
 | Phialogics - The immune tolerance company Our R&D platform is focused on developing immune modulating therapeutics for patients with autoimmune diseases. Our immune checkpoint activators protect patient’s organ tissue. Unique approach : - Potential for BEST-in-class super agonist against immune-mediated tissue damage - High selectivity for active T-cells - Proof of concept in relevant human in vitro models and mouse model of disease Type: | 1 | 0 | 1 | 6 |
 | PureIMS 🫁 Improving the health and lives of patients through effective, safe and convenient inhaled drug delivery PureIMS is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops®. The focus is on the treatment of systemic and respiratory diseases with significant unmet medical need. The company’s leadership team consists of seasoned life sciences executives who bring long-lasting and complementary experience in leading drug development, addressing applicable scientific issues and pursuing commercial and business development & licensing opportunities. They obtained their experience in leading positions with mid-size and top-5 global … Type: | 0 | 0 | 0 | 10 |
 | Mosaic TX An oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients. ABOUT US Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety … Type: | 2 | 1 | 1 | 32 |
 | MINAGRO - Maximize Your Impact Minagro supports agribusinesses by proposing greener solutions to improve the global impact of the agricultural sector. Founded in 2019, Minagro develops high-quality green products for crop care. Its greener solutions, based on sustainable raw materials, aim to improve crop protection and nutrition inputs while limiting the crop care industry’s impact on the environment. Located in Louvain-la-Neuve, Minagro conducts research activities in confirmed proprietary technologies from green and specialty chemistries. Minagro’s solutions are dedicated to contributing positively to environmental challenges by supporting agrochemical companies with green and safer ingredients such as in-can preservatives, adjuvants, solvents and bio-stimulant actives. renewable chemicals, sustainable … Type: | 2 | 0 | 2 | 4 |
 | Akthelia Pharmaceuticals Modulating innate immunity to improve cancer therapy outcomes. . Akthelia Pharma is a late preclinical-stage immunotherapy company, with its HQ in Iceland, targeting a huge unmet opportunity to improve cancer and cell/organ transplant outcomes through reducing the risk of neutropenic sepsis. This potentially fatal complication of systemic anticancer treatment, where a combination of reduced neutrophil count and loss of GI integrity results in bacteremia from the patient's own microbiome, is the leading cause of death associated with chemotherapy (up to 20% mortality) -- other than disease progression. Our breakthrough patented strategy, which is supported by world-leading KOLs, is to specifically … Type: | 0 | 0 | 0 | 4 |
 | Alia Therapeutics On-target gene therapies Alia Therapeutics is a pioneering gene editing company with a vision to revolutionize medicine by curing genetic diseases at their roots. Alia’s versatile portfolio of novel CRISPR systems expands the range of targetable genomic sites and increases the precision of genetic modifications, bringing gene editing to the next level of specificity and safety, which are required for therapeutic applications. Type: | 0 | 0 | 0 | 14 |
 | EOXsense Biochemical Sensors for a Better World A Breakthrough in Biochemical Sensing. We simplify people’s lives, adapting our technologies to their needs and habits with non-invasive physiological biomarker sensors. With low cost, fast, simple, and robust sensors we save lives. | 0 | 0 | 0 | 4 |
 | Sequana Medical NV Pioneers in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer Sequana Medical NV is a pioneer in treating drug-resistant fluid overload, a serious and frequent clinical complication in patients with liver disease, heart failure and cancer. Fluid overload is a well-recognized problem in these growing diseases, causing severe problems for the large number of patients for whom current medicines are no longer effective. These patients can have up to 15 liters of extra fluid in their bodies, causing major medical issues including increased mortality, repeated hospitalizations, severe pain, difficult breathing and restricted mobility that severely … Type: | 0 | 0 | 0 | 67 |
 | ExoMatter Because Materials Matter. The ExoMatter Materials R&D Platform generates a personalized shortlist of the most suitable materials for your applications. Drawing on materials data from numerous scientific sources - and/or your own data - and utilizing AI, ExoMatter enriches the data and allows you to apply a wide range of multidimensional physical, chemical and engineering criteria as well as sustainability attributes and anticipated cost. ExoMatter was a spin off from the German Aerospace Center in 2022 and participated in entrepreneurship programs of the reputable Munich UnternehmerTUM. Some of Germany’s largest enterprises such as Audi, Infineon and Airbus have relied on … Type: | 8 | 1 | 6 | 13 |
 |  FIREUP Cookware Iconic design. Incredible cooking. The first real innovation in cast iron in a century. Kickstarter live at link in bio! Iconic design. Incredible cooking. The first real innovation in cast iron cookware in nearly a century. Buy now at https://www.fireupcookware.com. Patented in 8+ countries, our technology was developed at the University of Oxford by a professor-student duo. What's different? Conventional cookware only heats from the bottom. Our patented fin design guides heat across the bottom and up the sides of the FIREUP Dutch oven, heating significantly faster and cooking more evenly. This results in more even cooking and baking, enhancing … | 0 | 0 | 0 | 1 |
 | MedicQuant ApS Rapid Answers For Better Treatment Our vision is to enable rapid and local tests for anticoagulants at the point-of-care to benefit patients. Currently, there is no readily available solutions to address blood levels of anticoagulants called Direct Oral Anticoagulants (DOACs) at the point-of-care. We have developed a novel technology, chip and instrument that can detect anticoagulants, directly from whole blood within only 10 minutes. The elegant simplicity of our solution will potentially be readily available at the point of care. Type: | 1 | 0 | 1 | 7 |
 | AMSilk GmbH | Biotech Materials 🌐 The first industrial supplier of advanced biomaterials made from spider silk-based proteins 🎯 Enabling true change AMSilk is a frontrunner in advanced biomaterials made from spider silk-based proteins. Using a patented technology platform, protected by a best-in-class patent portfolio, we are pushing boundaries in the field of bio-based materials. At AMSilk, we turn man-made proteins into formulations, including fibers and yarns, hydrogels and silk powder. The high-performance qualities of our material enable a wide range of applications in the textile, homecare, biomedical, and automobile industries and bring breakthrough benefits for products and customers. biotech, biotech materials, biopolymers , zero-waste … Type: | 3 | 1 | 2 | 73 |
 | Bioretec Ltd. better healing - better life Bioretec Ltd. is a medical device company focusing on the development of strong, safe and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. Our products are used worldwide, and we continue to further develop materials and products for load-bearing clinical applications. biomaterials, medical, manufacturing, medical devices, implants, absorbable metal, biopolymers, orthopaedics, and pediatric surgery Type: | 0 | 0 | 0 | 36 |
 | Virtonomy.io Accelerate and de-risk medical device development with digital patient twins and simulation Virtonomy introduces v-Patients, enabling medical device developers to perform development and testing in a virtual environment, thereby accelerating development, reducing risks, expenses, and regulatory burden. Our end-to-end digital twin and simulation solution is based on an ever-expanding database of real clinical data to reflect anatomical variability, demographic diversity and pathological conditions. digital health, virtual patients, digital twins, clinical trials, simulation, machine learning, AI, SaaS, simulated trials, cardiac database, and medtech Type: | 4 | 0 | 4 | 26 |
 | OncoLize OncoLize develops injectable drug depots to treat rare and deadly tumour diseases. Using thin needles or catheters, we localize the small drug depot inside the solid tumour. While graudally eroding away, the depot slowly releases a range of well-known drugs inside the tumour. This is done at much higher concentrations than ever possible via oral medication or intravenous injections, yet the total load of the drug is limited to the volume of the tumour. The benefits are relevant: better treatment options for the patient and the doctor, with far less side-effects, and at much lower costs. We will start with … Type: | 0 | 0 | 0 | 3 |
 | Adcendo ADCs, Copenhagen, Denmark. Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen. Type: | 1 | 0 | 1 | 42 |
 | Novostia Heart valves for life, for patients of any age, including children Novostia is a privately held medical device company developing an innovative artificial heart valve, designed for patients of any age, including children. Novostia endeavors to advance its technology to clinical trials and regulatory approvals to improve the quality of life of millions of people worldwide suffering from aortic and mitral valve disease. For more information please visite www.novostia.com Heart Valves and Medical Devices Type: | 0 | 0 | 0 | 17 |
 | hemotune AG We are a Swiss company on a mission to combat sepsis through magnetic blood purification. Member of @Wyss Zurich. We are a start-up medical device company originating from ETH Zurich and are passionate about developing life saving therapies. Our mission is to develop a breakthrough medical device for the most urgent healthcare issues. Focusing on patients’ needs, we translate the most promising research to the clinics and ensure patient access to scientific progress as soon as possible. As pioneers we take courageous decisions and are shaping the future of medicine. We first focus on finding an efficient therapy for patients … Type: | 3 | 0 | 1 | 27 |
 | Neurosoft Bioelectronics Soft implantable brain computer interfaces At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible. Type: | 3 | 2 | 2 | 16 |
 | Positrigo Imaging Everyone Dementia is a major problem in our aging societies costing nearly a trillion USD worldwide per year. Treatments are on the horizon, but an affordable and widely available diagnostic technique is still missing. Positrigo’s brain positron emission tomography system offers functional brain imaging to everyone at a fraction of today’s cost. Medtech, Brain PET, Functional Imaging, Alzheimer's disease, Nuclear Medicine, and Start up Type: | 2 | 0 | 2 | 27 |
 | Polariton Technologies Ltd. The World’s Fastest and Smallest Electro-Optic Modulators The world’s fastest and smallest electro-optic modulators, breaking the interconnect bottleneck. Polariton Technologies builds the fastest and smallest electro-optic modulators. Our plasmonics modulators demonstrated to be more than 10-times faster than state-of-the-art photonic modulators (500 GHz world record in the lab). At the same time, the modulators are 100-times more compact, more energy-efficient, and potentially cheaper in production. These world-records are enabled by Polariton Technologies’ plasmonic modulator technology. The tight confinement enables our modulators to efficiently modulate light on an ultra-compact footprint. The short interaction length, typically in the range of 10 μm, … | 5 | 2 | 1 | 21 |
 | Hylomorph preventing post-operative complications in implantable medical devices Hylomorph is an innovative Medtech company engineering biomaterials to optimize the interface between implants and their surrounding biological tissues. We aim at preventing post operative complications in implantable medical devices. Our mission is to improve quality of life in patients and the quality of care by health professionals. Our proprietary CellSense technology was developed in the cutting-edge laboratories of the Swiss Federal Institute of Technology (ETH Zurich). Hylomorph's first product, Hylomate, has demonstrated outstanding performance in limiting the foreign body reaction and fibrotic buildup in pre-clinical settings and is currently undergoing first-in-man … Type: | 1 | 0 | 1 | 13 |
 | CompPair Technologies Ltd. Enabling embedded ultra-fast repair for composite materials CompPair has developed a new material enabling an ultra-fast embedded repair. Our material is a composite: a high-performance, light-weight material made of strong fibers embedded in a matrix. Composites are widely used today in various industries such as sporting goods, marine, and aerospace applications. Inspired by the human body, our prepregs, HealTech, bring the healing capability of our flesh to composites: composites are now able to fully heal matrix damage in 1 minute. Our technology acts during the whole lifetime of products, helping clients, consumers, and the planet. For clients, CompPair makes production … Type: | 10 | 2 | 2 | 25 |
 | CUTISS AG Personalized & bioengineered human skin tissue therapy for patients with severe burns and skin injuries Our mission: to give patients back more of their own skin to make them well again. CUTISS is a Swiss clinical-stage life sciences company focussed on regenerative medicine, skin tissue engineering, and skin pigmentation. We are developing the first personalized and automated skin tissue therapy offering life-saving and life-changing medical treatments for patients with severe skin injuries. Our lead product denovoSkin promises to take skin surgery to the next level and revolutionize current treatments. It is a bio-engineered and personalized dermo-epidermal human skin graft, currently … Type: | 6 | 1 | 5 | 53 |
 | Limula Cell & Gene Therapy: Automated. Scalable. Accessible Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics. Bioproduction, Immunooncology, Cell therapy, Biotechnolgoy, Manufacturing, and CAR-T Type: | 1 | 1 | 0 | 19 |
 | Atinary Technologies No-code ML optimization platform for data-driven experimental planning and accelerated R&D. Atinary is a machine learning deeptech startup based in Lausanne and Silicon Valley. Atinary accelerates R&D and discovery of breakthrough molecules and materials with ML. The sweet spot applications are in formulation, catalysis, and synthesis for the pharma, biotech, food, chemicals, energy, and climate tech industries. Atinary is committed to addressing global challenges and inspiring a future where science and innovation know no bounds. The name Atinary comes from the verb in Spanish "atinar", which means hit, as in hit the target. Atinary's leading ML technology optimizes experimental planning, … Type: | 2 | 0 | 1 | 17 |
 | EggField Science driven protein company focusing on egg alternatives and helping gastronomy and industry to plant based growth. Pflanzliche Ei-Alternativen vom Feld für Industrie und Gastronomie. natürlich - clean label - ökologisch - vegan - swiss made Type: | 3 | 2 | 1 | 11 |
 | ZuriMED Technologies AG Advanced Swiss Medical Technologies We are an innovative Swiss start-up that spun off from the Institute for Biomechanics at ETH Zurich in 2015. At ZuriMED we strive to revolutionize soft tissue repair in orthopaedic sports medicine by developing breakthrough technologies and products. Our current focus lies in the augmentation of rotator cuff repair using our novel FiberLocker® System Type: | 0 | 0 | 0 | 19 |
 | Ariceum Therapeutics Developing novel drugs for systemic targeted radiotherapy (STR) Ariceum Therapeutics is a private clinical-stage radiopharmaceutical company focused on the diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers. Our lead targeted systemic radiopharmaceutical product, 177 Lu-satoreotide tetraxetan (Satoreotide), is an antagonist of the somatostatin type 2 receptor (SSTR2) which is overexpressed in many neuroendocrine tumours. We are developing satoreotide as a ‘theranostic’ pair for the combined diagnosis and targeted radionuclide treatment of neuroendocrine cancers, certain aggressive tumours and childhood cancer, which currently has few treatment options and a poor prognosis. Ariceum Therapeutics was launched in 2021, following … Type: | 1 | 1 | 1 | 35 |
 | Alentis Therapeutics We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis Alentis Therapeutics, the Claudin-1 (CLDN1) company, is a clinical stage biotechnology company on a mission to develop first-in-class antibodies and ADCs for CLDN1+ tumors and organ fibrosis. Alentis is pioneering a novel approach to modify and reverse the course of disease progression targeting CLDN1, a previously unexploited target that plays a key role in the pathology of tumors and fibrotic diseases across multiple organs. Alentis is the only company developing potential treatments for solid cancers and fibrosis targeting CLDN1. Alentis’ portfolio of anti-CLDN1 monoclonal antibodies includes a novel class of … Type: | 6 | 0 | 0 | 63 |
 | Zetta Genomics Ltd The Genome Optimised Data Store: Enabling healthcare transformation using big data technology Zetta Genomics unleashes the power of precision medicine – shaping the future of genomic data to transform the health of millions of people around the world. bioinformatics, genomics, genomic medicine, precision medicine, and biomedical research Type: | 1 | 0 | 1 | 33 |
 | NunaBio Limited Synthetic DNA production for cutting-edge biotechnology solutions. NunaBio is a privately-owned specialist DNA synthesis and development company. We are engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities. The company has built a solid reputation for its R&D flexibility and innovative approach to complex and challenging projects. NunaBio’s core expertise is research and development into cell-free DNA synthesis, process optimisation, route design, scale-up and small-scale manufacture for clinical studies. DNA, Custom DNA, Gene Synthesis, Synthetic Biology, Biotechnology, and DNA Synthesis Type: | 4 | 0 | 3 | 19 |
 | Manus Neurodynamica Prioritising Parkinson's Disease and other neurological conditions with earlier diagnosis and appropriate care. Manus Neurodynamica is revolutionising health care management by developing and patenting neuroscience technologies that record recognised biomarkers of neuromotor impairments which can radically improve patient diagnosis and disease monitoring. Our disruptive technology has potential to be used across applications such as screening, rehabilitation and drug development and medicine optimisation, streamlining referrals, reducing costs and increasing the efficiency of specialist services. We are looking for interested researchers, clinicians and practitioners to collaborate in situ assessment and testing of the NeuroMotor pen, as well as investors for the further … Type: | 1 | 0 | 1 | 16 |
 | Allegro Biotech Regenerative Biomedical Technology Allegro designs and develops a breakthrough biomedical nanotechnology for orthopedics, rheumatology and regenerative medicine. | 1 | 1 | 0 | 6 |
 | Dyneval A Platform Technology for Motility Measurement Dyneval’s innovative technology provides precise measurement of semen quality using portable equipment. It is the first technology capable of measuring the lifetime of semen motility in quasi- in-vivo conditions, thus providing new insights into the behaviour of spermatozoa prior to conception. We are fulfilling our vision to become the experts’ choice for semen quality assessment. Vets and genetics companies are using this data to inform breeding plans and confirm quality at every stage across the supply chain to ensure that livestock production is more efficient, improving food security while reducing the intensity of methane … Type: | 1 | 0 | 1 | 10 |
 | Scan.com Making medical imaging accessible to everyone around the world Join us to shape the future of diagnostic imaging, 10% of the world's healthcare market! Having already built the UK's largest marketplace for self-pay MRI scans, we are expanding at an incredible pace with the aim of becoming the world's largest diagnostic imaging platform. Our mission is simple, to make medical imaging accessible to everyone around the world. By doing this, we will save countless lives. Layer by layer, piece by piece, we’re rebuilding the infrastructure that underpins the medical imaging ecosystem to bring it into the modern era and usher … Type: | 2 | 1 | 1 | 80 |
 | CHARM Therapeutics Harnessing the power of deep learning to deliver therapeutics of transformational efficacy for patients. CHARM Therapeutics is discovering and developing small molecule medicines against difficult-to-drug targets with our proprietary 3D deep learning-enabled platform, DragonFold. Powered by the first high throughput protein-ligand co-folding algorithm and a world-class team of scientists and engineers, CHARM seeks to deliver innovative approaches to create life-changing therapies for patients. Type: | 5 | 0 | 5 | 61 |
 | CILIATECH - Glaucoma Innovators Developing a new class of supraciliary implant for treating glaucoma CILIATECH is a medtech company specialized in ophthalmology, developing a new class of implant to address the increasing need to treat glaucoma durably with a novel design. Founded in 2017 by ophthalmic surgeon and inventor Dr. Philippe Sourdille and Olivier Benoit, a veteran engineer and biotech entrepreneur, CILIATECH developed the CID (Cilio-scleral Inter-positioning Device) groundbreaking concept ‘CID’ is the first implant in the industry to reduce IntraOcular Pressure (IOP) without needing to access the anterior chamber or create a subconjunctival filtration bleb. The device is implanted as a standalone procedure … Type: | 1 | 1 | 0 | 7 |
 | Diatech Pharmacogenetics Leader in the development, production and sales of pharmacogenetics tests for cancer precision medicine. Diatech Pharmacogenetics, the leading Italian Precision Medicine company. Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine. The company aims at simplifying complex molecular diagnostic procedures into easy end-to-end solutions, from nucleic acids extraction and their molecular analysis, to final reporting. The company has 10 years of experience in the successful implementation of several nucleic acid analysis technologies into regulated diagnostic pipelines; examples include pyrosequencing, mass spectrometry and digital molecular barcoding. Leading cancer centres in Italy and abroad rely on Diatech CE-IVD solutions … Type: | 3 | 1 | 1 | 64 |
 | Complement Therapeutics Developing the next generation of complement medicines Complement Therapeutics GmbH (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade. Our lead investigational product (CTx001) is being evaluated as a potential gene therapy for dry age-related macular degeneration/geographic atrophy, a leading cause of blindness. Additional programmes will evaluate potential therapeutic opportunities in other complement-mediated conditions. The Company is also developing a unique quantification methodology, the … Type: | 3 | 0 | 2 | 28 |
 | Odimma Therapeutics Empowering Personalized Immunotherapy to Treat Cancer Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy. Immunotherapy has revolutionized the treatment of many advanced cancers. Despite this amazing achievement, significant clinical benefits are still limited to 10 to 30% of patients. Odimma believes in the future of precision medicine, and leverages recent advances in the field of immuno-oncology to amplify the efficacy of current therapies, improving lives and making each patient unique. By harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens, Odimma has … Type: | 10 | 3 | 8 | 7 |
 | Curileum Discovery Ltd Curileum is intervening early in serious gastrointestinal (GI) disease development with novel diagnostics & therapeutics Curileum is intervening early in serious GI disease development with novel therapeutics to detect and correct cell production in the gut mucosa Biotechnology Type: | 0 | 0 | 0 | 4 |
 | BoobyBiome Bringing better health to every baby. Our vision is to provide every baby with a breast milk microbiome, for equal access to a healthy future. Type: | 2 | 0 | 1 | 10 |
 | TC BioPharm Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations. Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, and Stratified Medicine Type: | 0 | 0 | 0 | 54 |
 | Graphene Composites Ltd We apply our core expertise in nanotechnology and advanced materials to turn innovative ideas into commercial realities. Excellence in Nanomaterials Engineering - GC is driven by an ethos to create life-changing products and a passion to bring nanomaterial engineering to life, for the good of humankind. We apply our expertise in graphene, aerogel and other nanomaterials to create breakthrough technologies and turn innovative ideas into commercial realities for our partners and customers. nanotechnology, graphene, aerogel, composites, bulletproof armour, stab-proof armour, lightning harvester, and virucidal ink Type: | 1 | 0 | 1 | 20 |
 | Arcede Pharma Aiming to provide improved treatments for chronic respiratory diseases through new, innovative drug substances Aiming to provide improved treatments for chronic respiratory diseases through new, innovative and patent protected substances, thereby reducing suffering and ameliorating quality of life for patients. Type: | 0 | 0 | 0 | 3 |
 | Samplix Reveal cell function with single-cell resolution. Samplix offers a cutting-edge droplet-based instrument for single-cell analysis in immunotherapy research. Our double emulsion technology enables seamless analysis and sorting on flow cytometers. Empower your research today! Xdrop encapsulates living cells and reactive molecules in highly stable double-emulsion droplets that act as microenvironments for rapid cell–cell and cell–molecule interactions during incubation. The droplets are suitable for flow cytometry and sorting. Xdrop Sort can both generate and sort double-emulsion droplets in a user-friendly workflow that does not require any experience with fluorescence-based cell sorters. The limited volume forces fast interactions and causes secreted substances … Type: | 2 | 0 | 2 | 38 |
 | InSphero Reliable, reproducible, and scalable 3D in vitro platforms for drug safety & efficacy testing | The Model of ExcellenceTM InSphero is the only 3D in vitro model company with the platform and expertise to modernize drug safety and efficacy testing in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow for more effective and safe therapies to get to the clinic faster due to our superior robustness, reliability, reproducibility, and scalability. InSphero’s goal is to help researchers fuel a new era of drug discovery through comprehensive products and services for: - Liver safety - … Type: | 3 | 0 | 0 | 71 |
 | Iconovo AB We bring inhalation expertise to your business Iconovo is a leading Swedish CDMO company, offering innovative and effective inhalation platforms to the international pharmaceutical industry. We have several types of patented dry powder inhalers that can create significant commercial opportunities for the development of both new pharmaceuticals and generic medicine. Our strength is our inhouse capabilities with full control over both device development and formulation, meaning less risk and faster time to market. Device development, DPI, and Inhalation | 2 | 2 | 2 | 42 |
 | New Wave Biotech Unleashing biotech innovation for a greener and fairer future For those creating a more sustainable future with biotechnology, we use AI and computational modelling to help precision fermentation alt protein companies optimise their downstream processing, so they can de-risk their ventures, speed up R&D and reduce costs. Biotechnology, Bioprocessing, Biomanufacturing, Precision Fermetation, ClimateTech, Alternative Protein, Computational Modelling, and Downstream Processing Type: | 7 | 2 | 5 | 7 |
 | Gearbox Biosciences Antibiotic-free recombinant protein production technology in E. coli Antibiotic-free protein production in E. coli protein production and synthetic biology Type: | 0 | 0 | 0 | 4 |
 | ATANIS Biotech AG We revolutionize allergy diagnosis ATANIS Biotech AG has been incorporated as a spin-off company from the University of Bern by the four co-founders Mrs. Noemi Zbären, Prof. Thomas Kaufmann, Prof. Alexander Eggel and Prof. Jean-Pierre Kinet in Summer 2021. The company has developed a novel functional cell based assay that massively simplifies the diagnosis of allergies and can predict treatment success of therapies. This test will additionally be used to assess safety and efficacy of potential new drug candidates for allergy treatment as well as for the evaluation of allergenicity of various food products. The proprietary assay is offered through … Type: | 0 | 0 | 0 | 14 |
 | Momo Medical Overzicht en rust voor de zorg. Goede nachtrust voor de bewoners. The Momo App assists caregivers in answering this question: "Who needs me?” With a single glance, the caregivers gain an overview of all residents in the nursing home. The Momo App enhances job satisfaction by enabling more person-centered care, reducing false alarms, and taking unnecessary check rounds and paperwork off their hands. For residents, the result is fewer falling incidents and better sleep. Type: | 0 | 0 | 0 | 86 |
 | Nemysis Ltd We are focussed on nutritional and pharmaceutical solutions to cope with Iron Deficiency/Anemia and Gluten Intolerance Based in Dublin, we are a highly focused team of senior individuals, with established networks and track records of research, entrepreneurial and investment success. Nemysis Ltd, a healthcare and pharmaceutical company, is focussed on nutritional and pharmaceutical solutions that can protect against some of the negative consequences of nutrient deficiency, nutrient intolerances and sensitivities, paying particular attention to the need to safeguard the human microbiome. · Nemysis' novel nanoparticulate iron is the first natural ferritin mimic, which can correct human iron deficiency and Anemia, … Type: | 0 | 0 | 0 | 7 |
 | Silicon Microgravity Ltd ..sensing the world Silicon Microgravity Limited (SMG) is a technology company focused on the inertial navigation and gravity markets. Over 10 years of research and development, first at Cambridge University's Nanoscience Department and then carried on inside SMG, has gone in to our resonant MEMS technology. Today SMG's team of scientists and engineers are based in our Technology Centre in Waterbeach, just north of Cambridge, England. SMG focuses on two markets. The inertial navigation market where our MEMS accelerometers and gyroscopes presently under development will provide higher accuracy, smaller form factor and lower cost than existing sensors. Then the gravity … Type: | 2 | 0 | 0 | 14 |
 | Delmic Powerful insights, simple workflows Delmic is a passionate high-tech company based in Delft, the Netherlands that develops powerful and user-friendly solutions for electron microscopy, bringing researchers and organizations closer to research insights across diverse application fields. Integration of light and electron microscopy fundamentally impacts imaging by creating the possibility to gain deep insight quickly, easily and reliably. Delmic’s mission is to empower researchers and companies by helping them achieve results that can be trusted implicitly with powerful and user-friendly solutions. Currently, Delmic has two main product lines: cathodoluminescence solutions (SPARC Spectral, SPARC Compact and JOLT) and correlative light and electron … Type: | 2 | 0 | 1 | 60 |
 | Aurealis Therapeutics Multi-target cell and gene therapies for unmet medical needs. Aurealis Therapeutics is a Swiss-Nordic Cell and Gene Therapy Platform Company. Our multi-target cell and gene therapy platform, based on genetically modified safe lactic acid bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers - deadly Cancers - Ovarian Cancer, Peritoneal Carcinomatosis - Inflammation. After successfully completing our Phase 1 clinical study in Diabetic Foot Ulcer (DFU) patients with our lead clinical product AUP-16, our DFU Phase 2 study is ongoing in Italy, Germany and Poland. Venous Ulcers and other ulcers will follow. In Oncology, … Type: | 1 | 0 | 1 | 17 |
 | Atrandi Biosciences | Droplet Genomics Microfluidics, Single-Cell Analysis, & High-Throughput Screening Atrandi Biosciences is breaking new ground in high-throughput analysis technologies. Providing simple-to-adopt and easy-to-use droplet microfluidics and high-throughput screening (HTS) workflows. Droplet microfluidics technology is at the core of our products and provides an unmatched platform for exploring the complexity of biology in a high-throughput manner. Droplet microfluidics enables compartmentalizing molecular biology reactions into millions of pico-liter droplets, empowering you to study biological samples at the resolution of single cells and single molecules. Our work is at the intersection of life sciences, engineering, and machine learning. We deliver elegant solutions and novel tools for … Type: | 2 | 1 | 1 | 51 |
 | Sirius Medical Moving from localization to Surgical Marker Navigation Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. The company is a spin-off of the Netherlands Cancer Institute, where researchers recognized the need to simplify and improve localization technology for the surgical removal of breast cancers. This led to the development and clinical demonstration of the first magnetic seed localization, a technique that Sirius Medical perfected and further developed into the Sirius Pintuition System. Today, Sirius Pintuition represents the next generation of tumor localization technology, known … Type: | 0 | 0 | 0 | 39 |
 | icometrix Transforming patient care through imaging AI Transforming patient care through imaging AI. Founded in 2011, icometrix (Leuven, Belgium; Boston, USA) strives for data-driven insights and personalized patient care, supported by artificial intelligence. icometrix offers a portfolio of AI solutions to assist healthcare with various challenges; icobrain extracts data from brain MRI and CT scans for the radiological reporting and clinical management of neurological disorders such as multiple sclerosis, brain trauma, epilepsy, stroke, dementia, and Alzheimer's disease. icompanion, a digital platform, and the mobile app helps people with MS and their care team to monitor clinical symptoms and treatments efficiently and … Type: | 1 | 0 | 1 | 61 |
 | SynapCon - Faster Clinical Trials (SaaS) AI & ML-based platform for Medtech, Biotech and Pharma SynapCon develops & distributes software for clinical trials, making the process faster, better and more cost-effective. We digitise the entire process of pharma, biotech or medtech clinical trials, making them easier to manage, much faster and much more cost effective! Saving millions of patients and healthcare dollars through better access to medicines and medical devices worldwide. AUDITED QUALIFIED SUPPLIER 2022/2023. Thanks to the EMA's recent Notice to Sponsors, there has never been a better time for our product to demonstrate its capabilities. Clinical Research, EU-GDPR, Compliance Management, Artificial Intelligence, CROIT (Clinical Research Operations Information Technology), Consultancy (Medical Development and IT), … Type: | 1 | 0 | 1 | 5 |
 | Sensible Biotechnologies Engineering cells to make better mRNA. At Sensible Biotechnologies, we are turning living cells into cost-efficient factories for manufacturing high-quality mRNA to unlock the full potential of mRNA therapeutics and vaccines. Type: | 1 | 0 | 1 | 17 |
 | Pinpoint Molecular Ltd For point-of-care solutions Providing low-cost and simple innovative solutions to point-of-care detection of diseases Type: | 0 | 0 | 0 | 2 |
 | Spirecut The future of hand surgery with ultrasound precision. Spirecut is a Swiss MedTech company. We improve treatments for trigger finger and carpal tunnel syndrome, which affect one in seven in their lifetimes. Spirecut's patented Sono-Instruments® are ultrasound-guided, incision-less, and non-invasive. Surgeons achieve greater accuracy, leading to better patient recovery and results. Spirecut's Sono-Instruments® are now available through a network of local distributors across several global markets, including Belgium, France, the UK, Ireland, Canada, and the United States. Contact us at info@spirecut.com to learn more. Medtech, Medical devices, Hand Surgery, Carpal Tunnel Syndrome, Trigger Finger, Swiss MedTech, Swiss SME, Medical devices … Type: | 2 | 0 | 1 | 6 |
 | Spore.Bio Lighting-up Microbiology Building a new generation of microbiological technologies | 6 | 3 | 3 | 21 |
 | PepKon PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers. These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families Type: | 7 | 5 | 5 | 6 |
 | Lucida Medical Ltd Medical device software using AI to find cancer precisely and fast with MRI, focusing on prostate cancer | Hiring now Lucida Medical develops software tools using AI and MRI, to support cancer screening, diagnosis and management. PiTM is a CE-marked medical device intended to help doctors find prostate cancer, the most common cancer in men, with outstanding clinical data, automation and workflow integration. Medical device, Artificial intelligence, Reporting, Medical imaging, MRI, Machine learning, Image enhancement, Oncology, Cancer diagnosis, and Cancer screening Type: | 2 | 1 | 2 | 17 |
 | FÆRM By mixing old traditions and creative science we work hard to democratise cheese 🧀🌱 We are FÆRM, a food tech company that uses science to further traditional cheese production methods, creating the future of non-dairy products. We re-design plant-masses to achieve the well-known textures and flavors from cheese to create taste experiences - unlike anything you’ve had before. | 2 | 1 | 1 | 11 |
 | HBOX Therapies Delivering therapies through targeted hyperoxygenation We are developing miniaturized hyperoxygenation therapies! The first application for our technology is miniaturized respiratory assist in patients suffering from lung failure. Type: | 2 | 0 | 2 | 7 |
 | SOMAÍ Pharmaceuticals We Craft Care At SOMAÍ, we are on a journey to build a leading global brand with the most robust portfolio of innovative cannabis-based therapeutics. We envision a world where people live healthy lifestyles empowered by natural cannabis medicine. Our company is dedicated to formulating innovative cannabis-based products to ensure a healthy and comfortable life. For that, we create a wide variety of medications for chronic patients and different conditions. We aim to design calm and satisfactory experience of administering, prescribing and purchasing cannabis-based medicine. SOMAÍ Pharmaceuticals is an EU-GMP European pharmaceutical and biotech company centered on manufacturing in Lisbon, … Type: | 0 | 0 | 0 | 45 |
 | Bioeureka [Automatic translation follows] A revolution for sample analysis! Bioeureka is an AI-powered image recognition application that recognizes, analyzes and interprets sample images. Biochemistry, Biotechnology, Microbiology, AI, Laboratory Technology, Data Collection, and Medical Device | 2 | 0 | 0 | 7 |
 | Novai DARC, a retinal biomarker with AI, advancing drug development for AMD & glaucoma therapeutics Early Detection Prevents Blindness and Disability: Novai is on a mission to combat blindness and disability by pioneering early detection and intervention for eye and brain diseases. At the heart of Novai's innovation is the DARC technology (Detection of Apoptosing Retinal Cells), a novel combination of a proprietary biologic and Artificial Intelligence (AI). The Eye is a Window on to the Brain: DARC stands alone as the sole technology with the ability to observe single cell stress and programmed cell death in the retina. This breakthrough … Type: | 8 | 1 | 7 | 16 |
 | Sun Bear Biofuture We're making sustainable world essentials using precision fermentation. Starting with Palm Oil. We believe that everyone should be able to make easy choices they know are sustainable and healthy. We are reimagining farming by blending the natural process of fermentation with modern science and technology, in order to make everyday essentials. We just happen to make a great alternative to palm oil. Type: | 6 | 0 | 6 | 9 |
Startup